Patient-Reported Outcomes in Adults With Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Treated With Ponatinib or Imatinib in Combination With Reduced-Intensity Chemotherapy: Results From the Phase III PhALLCON Study

Autor: Ashaye, Ajibade, Shi, Ling, Aldoss, Ibrahim, Montesinos, Pau, Vachhani, Pankit, Rocha, Vanderson, Papayannidis, Cristina, Leonard, Jessica T., Baer, Maria R., Ribera, Jose-Maria, McCloskey, James, Wang, JianXiang, Jin, Jie, Gao, Sujun, Rane, Deepali, Guo, Shien
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S161-S161
Databáze: ScienceDirect
Externí odkaz: